Page Updated: Saturday, July 18, 2026 1:05 PM ET

CNBC - Health

Fat cat? Weight-loss drugs may be coming for your overweight pet

11 hours ago

Trump rips Canada for wildfire smoke, threatens to raise tariffs

11 hours ago

Taco Bell says it has removed lettuce linked to cyclosporiasis outbreak from its restaurants

18 hours ago

World's largest olive oil company says market has 'definitively' entered new phase

1 day ago

Buy the contractor before the renovation is complete: This stock's next growth phase is taking shape

1 day ago

3 of our stocks rode the AI rally, while 3 others fell out of favor since last month

2 days ago

Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion

2 days ago

UnitedHealth beats quarterly estimates, hikes profit outlook

2 days ago

J&J falls despite a beat-and-raise quarter. Why we're raising our price target anyways

2 days ago

Biotech's recovery isn't a 'head fake.' These 3 stocks could lead the next leg up

4 days ago

A tiny GLP-1 implant is the latest bet to help patients maintain weight loss

4 days ago

AstraZeneca's trial flop raises a bigger question: Is its pipeline premium too vulnerable?

7 days ago

Abivax $920 million cash haul lets it prepare for solo U.S. launch instead of relying on a buyer

7 days ago

AstraZeneca stock drops after clinical trial miss deals rare blow to pharma powerhouse

8 days ago

Employers aren't expanding coverage of GLP-1 obesity drugs, survey says

9 days ago

Jim Cramer says these are the 5 stocks to buy during this market rotation

11 days ago

Ebola outbreak harder to contain after USAID, Western aid cuts, experts say

11 days ago

Jim Cramer says this former Covid market darling is finally investable again

16 days ago

Walmart, CVS step in to help seniors with Medicare coverage of obesity drugs

16 days ago

FDA lets Philip Morris market Zyn nicotine pouches as less harmful than cigarettes

18 days ago

Cramer says this aerospace stock is significantly undervalued, sees 35% upside

18 days ago

Medicare will start covering obesity drugs. Here's what patients should know

18 days ago

French biotech stock soars 40% after new data on experimental medicine

18 days ago

FDA names first companies chosen for faster review of new manufacturing plants

18 days ago

Medicare is about to cover obesity drugs — but many seniors may not know it yet

20 days ago

Estrogen patches are hard to find, and it may not be resolved any time soon

22 days ago

Chan Zuckerberg Initiative's Biohub to open new rare disease funding round

23 days ago

This life sciences stock has a secret weapon, and AI will only make it more valuable

23 days ago

Extreme heat grips Europe as red alerts issued in UK, France, Spain and Italy

23 days ago

UPS to invest $48 million in cold facilities amid GLP-1 boom

25 days ago

SNAP restrictions could change what shoppers buy — and food giants are watching

28 days ago

U.S. opens tariff probe targeting Germany's drug pricing policies

29 days ago